Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
Accesswire
*New analysis suggests efficacy of Xifaxan to mitigate OHE rehospitalizations irrespective of treatment history*
*LAVAL,..
